These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 9717770

  • 1. Effects of talipexole on contraversive rotation and functional impairment in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF, Ni L, Zhang H, Kohno Y, Sasa M.
    Jpn J Pharmacol; 1998 Jul; 77(3):227-33. PubMed ID: 9717770
    [Abstract] [Full Text] [Related]

  • 2. Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys.
    Domino EF, Ni L, Zhang H, Kohno Y, Sasa M.
    Eur J Pharmacol; 1997 May 01; 325(2-3):137-44. PubMed ID: 9163560
    [Abstract] [Full Text] [Related]

  • 3. Effects of pramipexole on contraversive rotation and functional motor impairments in 1-methyl-4-phenyl1,2,3, 6-tetrahydropyridine-induced chronic hemiparkinsonian monkeys.
    Domino EF, Ni L, Zhang H, Kohno Y, Sasa M.
    J Pharmacol Exp Ther; 1998 Dec 01; 287(3):983-7. PubMed ID: 9864283
    [Abstract] [Full Text] [Related]

  • 4. Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-dopa and as chronic treatment.
    Irifune M, Nomoto M, Fukuda T.
    Eur J Pharmacol; 1994 Oct 24; 264(2):117-23. PubMed ID: 7851473
    [Abstract] [Full Text] [Related]

  • 5. Nicotine alone and in combination with L-DOPA methyl ester or the D(2) agonist N-0923 in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF, Ni L, Zhang H.
    Exp Neurol; 1999 Aug 24; 158(2):414-21. PubMed ID: 10415147
    [Abstract] [Full Text] [Related]

  • 6. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF, Sheng J.
    J Pharmacol Exp Ther; 1993 Jan 24; 264(1):221-5. PubMed ID: 8093726
    [Abstract] [Full Text] [Related]

  • 7. Trihexyphenidyl interactions with the dopamine D1-selective receptor agonist SKF-82958 and the D2-selective receptor agonist N-0923 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF, Ni L.
    J Pharmacol Exp Ther; 1998 Jan 24; 284(1):307-11. PubMed ID: 9435192
    [Abstract] [Full Text] [Related]

  • 8. Protective effect of talipexole on MPTP-treated planarian, a unique parkinsonian worm model.
    Kitamura Y, Kakimura J, Taniguchi T.
    Jpn J Pharmacol; 1998 Sep 24; 78(1):23-9. PubMed ID: 9804058
    [Abstract] [Full Text] [Related]

  • 9. Biperiden enhances L-DOPA methyl ester and dopamine D(l) receptor agonist SKF-82958 but antagonizes D(2)/D(3) receptor agonist rotigotine antihemiparkinsonian actions.
    Domino EF, Ni L.
    Eur J Pharmacol; 2008 Dec 03; 599(1-3):81-5. PubMed ID: 18851961
    [Abstract] [Full Text] [Related]

  • 10. Effects of talipexole on motor behavior in normal and MPTP-treated common marmosets.
    Irifune M, Nomoto M, Fukuda T.
    Eur J Pharmacol; 1993 Jul 20; 238(2-3):235-40. PubMed ID: 8104807
    [Abstract] [Full Text] [Related]

  • 11. Selective full dopamine D1-like (SKF-82958) and D2-like (N-0923) agonist combination in the MPTP monkey model of hemiparkinsonism.
    Domino EF.
    Brain Res Bull; 1997 Jul 20; 43(1):93-5. PubMed ID: 9205801
    [Abstract] [Full Text] [Related]

  • 12. Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys.
    Schneider JS, Sun ZQ, Roeltgen DP.
    Brain Res; 1994 Nov 07; 663(1):140-4. PubMed ID: 7850462
    [Abstract] [Full Text] [Related]

  • 13. Anti-tremor activity of talipexole produced by selective dopamine D2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum.
    Kohno Y, Fukuzaki K, Kitahara K, Koja T.
    Eur J Pharmacol; 1997 Jan 29; 319(2-3):197-205. PubMed ID: 9042591
    [Abstract] [Full Text] [Related]

  • 14. Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys.
    Domino EF, Sheng J.
    J Pharmacol Exp Ther; 1993 Jun 29; 265(3):1387-91. PubMed ID: 8099621
    [Abstract] [Full Text] [Related]

  • 15. Differential recovery of volitional motor function, lateralized cognitive function, dopamine agonist-induced rotation and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion.
    Schneider JS, Lidsky TI, Hawks T, Mazziotta JC, Hoffman JM.
    Brain Res; 1995 Feb 20; 672(1-2):112-7. PubMed ID: 7749732
    [Abstract] [Full Text] [Related]

  • 16. MPTP-Induced hemiparkinsonism in nonhuman primates 6-8 years after a single unilateral intracarotid dose.
    Emborg-Knott ME, Domino EF.
    Exp Neurol; 1998 Aug 20; 152(2):214-20. PubMed ID: 9710520
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
    Yoshimura N, Mizuta E, Yoshida O, Kuno S.
    J Pharmacol Exp Ther; 1998 Jul 20; 286(1):228-33. PubMed ID: 9655864
    [Abstract] [Full Text] [Related]

  • 18. Trihexyphenidyl potentiation of L-DOPA: reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF, Ni L.
    Exp Neurol; 1998 Aug 20; 152(2):238-42. PubMed ID: 9710523
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.
    Kitamura Y, Kohno Y, Nakazawa M, Nomura Y.
    Jpn J Pharmacol; 1997 May 20; 74(1):51-7. PubMed ID: 9195297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.